多发性硬化症中的T淋巴细胞亚群——它们有助于判断免疫抑制治疗吗？
T-lymphocyte subpopulations in multiple sclerosis--do they help to judge immunosuppressive therapy?
作者信息
Henneberg A, Fischer E G, Kornhuber H H
机构信息
Department Neurology, University of Ulm, Federal Republic of Germany.
出版信息
Eur Arch Psychiatry Neurol Sci. 1988;238(2):94-6. doi: 10.1007/BF00452783.
PMID:2850189
Abstract
T-cell subpopulations were tested in multiple sclerosis (MS) patients before and after cyclophosphamide (n = 38) and corticotropin (n = 37) treatment and physiotherapy (n = 30). There were no specific changes of subset ratios immediately after immunosuppressive treatment. However, T-cell subpopulations showed great day-to-day variations in MS patients.
摘要
在环磷酰胺（n = 38）、促肾上腺皮质激素（n = 37）治疗及物理治疗（n = 30）前后，对多发性硬化症（MS）患者的T细胞亚群进行了检测。免疫抑制治疗后即刻，亚群比例无特定变化。然而，MS患者的T细胞亚群表现出很大的每日变化。
Zotero 插件